Search for: "Pfizer Inc."
Results 1 - 20
of 1,503
Sort by Relevance
|
Sort by Date
20 Oct 2023, 6:37 am
Pfizer Inc Agrees to Pay $2M to Resolve Alleged Compensation Discrimination at New York City Location SBA Administrator Guzman and Business Leaders Reaffirm Support for 8(a) Program If it does get passed, the Defense authorization bill has quite a few surprises Florida International University Agress to Pay $575K in Back Wages, Interest to Resolve Alleged Gender Pay Discrimination Former Navy IT Manager Sentenced to over 5 Years in Prison for Hacking a Computer… [read post]
19 Oct 2023, 8:59 am
[LexisNexis Commentary: This IMR is particularly interesting because the medication Geodon, which was at issue here, was the subject of a $301 million settlement between Pfizer, Inc. and the U.S. [read post]
31 Aug 2023, 11:01 am
As for vendors, naturally the top vendors are almost all giants, such as Pfizer, Lockheed Martin, and Raytheon. [read post]
29 Aug 2023, 4:15 am
Pfizer, Inc. and BioNTech SE on Monday hit back at competitor COVID-19 vaccine maker Moderna with inter partes review (IPR) petitions against two Moderna patents on mRNA vaccine technology at the Patent Trial and Appeal Board (PTAB). [read post]
29 Aug 2023, 4:15 am
Pfizer, Inc. and BioNTech SE on Monday hit back at competitor COVID-19 vaccine maker Moderna with inter partes review (IPR) petitions against two Moderna patents on mRNA vaccine technology at the Patent Trial and Appeal Board (PTAB). [read post]
10 Jul 2023, 6:47 am
The SEC also brought charges against five individuals, including a Massachusetts police chief, in connection with their trading before the announcement of an offer by Alexion Pharmaceuticals Inc. to acquire Portola Pharmaceuticals Inc. [read post]
6 Jul 2023, 6:11 am
., Inc., 132 S. [read post]
29 Jun 2023, 8:21 am
The Securities and Exchange Commission today announced insider trading charges against Amit Dagar, a former Pfizer Inc. employee, and his close friend and business partner, Atul Bhiwapurkar, for trading in advance of the company’s November 5, 2021,…Read the Full Press Release Have a securities law question? [read post]
20 Jun 2023, 5:55 am
Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUAs) for the Pfizer, Inc. and the ModernaTX, Inc. [read post]
9 Jun 2023, 8:36 am
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
9 Jun 2023, 8:36 am
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
14 May 2023, 11:28 am
Facebook Inc., 2023 WL 3362592 (N.D. [read post]
16 Apr 2023, 9:40 pm
Bauer, Retired, Medtronic, Inc.; Dean Harts of 3M Innovative Properties Co.; Sharon Reiche of Pfizer Inc.; and Bill Warren of Eversheds Sutherland, who were involved in the preparation of IPO's comments, will cover issues such as trade secret protection, counterfeiting, compulsory licenses, issues in IP enforcement, genetic resources and an overview of developments at multilateral organizations. [read post]
5 Apr 2023, 5:18 am
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
14 Mar 2023, 11:48 pm
Pfizer, Inc., 2009 WL 3320272, at *2 (N.D. [read post]
24 Feb 2023, 5:40 am
Reuters reports that the US Supreme Court “turned away Pfizer Inc’s bid to revive its plan to cover out-of-pocket expenses of Medicare patients for drugs costing $225,000 a year to treat a rare heart condition,” transthyretin amyloid cardiomyopathy, “after federal officials found that the drugmaker’s arrangement could amount to illegal kickbacks. [read post]
14 Feb 2023, 12:29 pm
</span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <p> <span style="display: initial;"> <span style="display: initial;"> Famous trademark infringement </span> </span> <a href="https://www.business.com/articles/5-trademark-cases-and-what-you-should-learn-from-them/"… [read post]
1 Feb 2023, 9:05 pm
Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6 acquisition of Biohaven Pharmaceuticals, $5.4 billion acquisition of Global Blood Therapeutics and $525 million acquisition of ReViral. [read post]
13 Jan 2023, 3:00 am
National/Federal At Proud Boys Trial, U.S. [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
